series	seriesDescription	geoAreaCode	geoAreaName	timePeriodStart	value	valueType	time_detail	upperBound	lowerBound	basePeriod	source	footnotes	Nature	Units	Reporting Type
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2010.0	20	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2011.0	24	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2012.0	27	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2013.0	29	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2014.0	28	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2015.0	32	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2016.0	33	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2017.0	35	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)	2018.0	34	Float					WHO and UNICEF HPV coverage estimates	['']	E	PERCENT	G
